Annual Report 2005-2006 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2005-2006. During the financial year, The Company’s Total Income Rs. 18060 million. Net Profit after Tax for the year Rs. 4613 million. Preference Share Rs. 1/-. Equity shares final Rs. 1023. Book value per equity share (Rs. 5 paid up) Rs. 79/-. During the year under review, The Company received notices from Foreign Currency Convertible Bond (FCCB) holders for exercising the conversion option in respect of 3500 FCCBs of US $ 1000 each out of 350,000 FCCBs. Accordingly, The Company allotted during the year ended 31^st March 2006, 216,007 equity shares of Rs. 5/- each of these bondholders at the conversion price of Rs. 729.30 per share.

The Board of Directors are pleased to recommend a preference share dividend of @6% p.a. on the paid up amount of outstanding preference shares which are still not redeemed, and equity dividend at the rate of @110% (previous year 75%) for the year ended 31^st March 2006 on the equity share capital.

More Annual Report of Sun Pharmaceutical Industries Limited: